TY - JOUR T1 - Multimodality imaging in carcinoid heart disease JF - Open Heart JO - Open Heart DO - 10.1136/openhrt-2019-001060 VL - 6 IS - 1 SP - e001060 AU - Ali M Agha AU - Juan Lopez-Mattei AU - Teodora Donisan AU - Dinu Balanescu AU - Cezar A Iliescu AU - Jose Banchs AU - Peter Y Kim AU - Nicolas L Palaskas AU - Syed Yusuf AU - Greg Gladish AU - Saamir Hassan Y1 - 2019/06/01 UR - http://openheart.bmj.com/content/6/1/e001060.abstract N2 - Neuroendocrine neoplasms arise from the gastrointestinal tract and can lead to carcinoid syndrome. Carcinoid heart disease affects more than half of these patients and is the initial presentation of carcinoid syndrome in up to 20 % of patients. Carcinoid heart disease typically leads to valve dysfunction, but in rare instances, carcinoid tumours can also metastasise to the endocardium and myocardium. Cardiovascular imaging plays an integral role in the diagnosis and prognosis of carcinoid heart disease. The use of multimodality imaging techniques including echocardiography, cardiac MRI, cardiovascular CT and positron emission tomography have allowed for a more comprehensive assessment of carcinoid heart disease. In this review, we discuss the features of carcinoid heart disease observed on multimodality imaging, indications for obtaining imaging studies and their role in carcinoid heart disease management. ER -